Remdesivir-induced severe hypoglycemia in an elderly man without diabetes: a case report.

ABSTRACT:

Background

Remdesivir is recommended to treat hospitalized patients with coronavirus disease 2019 (COVID-19). Remdesivir is known to affect glucose metabolism in individuals with and without diabetes. However, little is known about the possibility of hypoglycemia associated with remdesivir. Our case is the first report demonstrating the development of severe hypoglycemia following remdesivir treatment in an elderly man without diabetes.

Case presentation

A 73-year-old man developed COVID-19 following surgery for sigmoid volvulus. The patient's medical history included surgery for posterior correction of scoliosis, Chiari malformation type I, and syringomyelia. There was no history of diabetes mellitus. The patient was started on remdesivir (200 mg on day 1, followed by 100 m

SUBMITTER: Nagano Y 

PROVIDER: S-EPMC11770970 | biostudies-literature | 2025 Jan

REPOSITORIES: biostudies-literature